Carey RM, Wright JT Jr, Taler SJ, Whelton PK
What GLP-1 Medications Actually Do to Your Body GLP-1 (glucagon-like peptide-1) receptor agonists work by: Suppressing appetite and increasing feelings of fullness Slowing digestion so you feel satisfied longer Regulating blood sugar and insulin response Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro) are now widely prescribed for weight loss and the WHO formally recognises them as valid obesity treatments
This is especially important given that fewer than 20% of employer health plans are expected to cover GLP-1 medications for weight loss by 2025
This creates a challenging atmosphere, said Collie James of Morgan Lewis
T2DM diagnosis and treatment trends Type 2 diabetes mellitus (T2DM) represents a significant global health challenge, with Asia being a major epicenter of its prevalence (1, 2)
Many patients reduce to half their peak dose once they reach stable weight